ConductScience.org, home

Comparison · NCT02923726-8e03cfdc

ATP and Shock vs Shock Only: Inappropriate Shock

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. ATP and Shock vs Shock Only: Inappropriate Shock. Trial comparisons, record NCT02923726-8e03cfdc. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02923726-8e03cfdc

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.03070.02260.0416wilson
Risk in group 20.0480.03760.061wilson
Risk difference, group 1 minus group 2-0.0172-0.0326-0.00223newcombe hybrid score
Risk ratio, group 1 over group 20.6410.4340.946log
Odds ratio, group 1 over group 20.6290.420.944log
Number needed to treat, for one fewer participant with the outcome on ATP and Shock than on Shock Only5830.7449from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1ATP and Shock
Once tachycardia has been detected and duration met, this group would receive antitachycardia pacing prior to shock therapy.~Arm 1 (ATP+Shock): Subjects will be randomized and device programmed to the respective arm.
401,302OG000
Group 2Shock OnlyOnce tachycardia has been detected and duration met, this group would receive shock therapy only.~Arm 2 (shock only): Subjects will be randomized and device programmed to the respective arm.621,293OG001

Outcome

Type
SECONDARY
Title
Inappropriate Shock
Description
incidence of first inappropriate shock All shocks delivered by the device were adjudicated by an external committee as to whether they were appropriately or inappropriately delivered. Inappropriate shocks contributed to the evaluation of this endpoint.
Time frame
5 years
Population
All randomized subjects.

Source ClinicalTrials.gov

Trial

Title
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
NCT number
NCT02923726
Phases
NA
Conditions
Sudden Cardiac Death
Interventions
Arm 1 (ATP+Shock), Arm 2 (shock only)
Lead sponsor
Boston Scientific Corporation
Results first posted
2024-10-22

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02923726-8e03cfdc